Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Mian: Affordable housing in God’s backyard

Affordable housing in God’s backyard: Some religious congregations find a new use for their space By Nadia Mian, Ph.D., Senior Program Director, Ralph W. Voorhees Center for Civic Engagement Faced with declining membership, aging buildings and large, underutilized...

Do you have one of the most common jobs in New Jersey?

Nearly 4.6 million people work in New Jersey in thousands of different types of jobs. But nearly 840,000 positions make up the top 10 most common roles, according to data from the U.S Bureau of Labor Statistics. Laborers and freight stock and material movers — those...

NJSPL – The New Jersey Induced Travel Calculator

By Robert B. Noland Induced travel occurs when new roads or lanes are built with the goal of reducing traffic congestion. What this means in practice is that new travel fills the new roads or lanes such that the goal of congestion reduction is not met. While many...

Kelly O’Brien (MCRP ’09) Named Fairfax City Hometown Hero

On July 15th, Kelly O'Brien (MCRP '09)  was recognized as a Hometown Hero during Fox 5 DC's Zip Trip visit to Fairfax City. "Although I don't think of myself as a hero, I am grateful for the chance to express my dedication to serving my community and shed light on the...

Winecoff: Working Paper on Health Insurance Enrollment

Spillovers in Public Benefit Enrollment: How does Expanding Public Health Insurance for Working-Age Adults affect Future Health Insurance Choices? Abstract Enrollment in one public benefit program often affects enrollment in others. We study life-course spillovers by...

Upcoming Events

Event Series CAREERS

Virtual Career Drop-ins

Virtual

Stop by virtually on Mondays (except for holidays) beginning September 9th through December 16th between 11 am and 1 pm to ask a quick (15 min) career-related question of Bloustein […]